宁波三星医疗电气股份有限公司关于股权激励限制性股票回购注销实施公告

Core Viewpoint - Ningbo SANSING Medical Electric Co., Ltd. announced the repurchase and cancellation of restricted stock due to five incentive targets no longer meeting the conditions for the incentive plan after leaving the company [2][20]. Group 1: Repurchase and Cancellation Details - The repurchase involves 41,800 shares of restricted stock from the fourth and fifth phases of the incentive plan [21]. - The company plans to complete the repurchase and cancellation by September 12, 2025, and will handle the necessary registration changes [22]. - Following the cancellation, the total share capital will decrease from 1,405,251,200 shares to 1,405,209,400 shares [23]. Group 2: Incentive Plan Implementation - The fourth phase of the incentive plan was approved on November 17, 2021, with 1,446.35 million shares granted to 189 eligible targets [5][6]. - The fifth phase was approved on January 24, 2022, with 762.2 million shares granted to 159 eligible targets [12][13]. - The company has conducted multiple meetings to review and approve adjustments to the incentive plans and the repurchase of shares [4][5][6][12][13]. Group 3: Compliance and Legal Assurance - The board of directors confirmed that the decision-making process and information disclosure comply with relevant laws and regulations [23]. - The company has ensured that all involved parties have been informed about the repurchase and cancellation, with no objections raised [23].